MELBOURNE, Australia, Jan. 28, 2025 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defense immune enhancers to minimize the impact of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback